In Vitro Fertilization Market

In Vitro Fertilization Market (Product: Equipment, Reagents & Media, and Accessories; and Type: Conventional IVF, IVF with ICSI, and IVF with Donor Eggs) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

In Vitro Fertilization Market Outlook 2034

  • The global industry was valued at US$ 781.1 Mn in 2023
  • It is estimated to grow at a CAGR of 6.2% from 2024 to 2034 and reach US$ 1.5 Bn by the end of 2034

Analyst Viewpoint

Rise in adoption of Assisted Reproductive Technology (ART) is augmenting the in vitro fertilization market size. ARTs have spread worldwide leading to the conception and birth of over eight million babies since being implemented in 1978.

Technological advancements in ART are also boosting the in vitro fertilization market development share. These advances include improvements in ovulation induction protocols, the introduction of recombinant gonadotropins, GnRH agonists, and GnRH antagonists.

Key players are focusing on advancements in cryopreservation techniques for in vitro fertilization. Freeze-all strategy has emerged as an accepted and valuable alternative to fresh embryo transfer in ART.

Market Introduction

In Vitro Fertilization (IVF) is an Assisted Reproductive Technology (ART) that helps a woman become pregnant. In this process, a woman's ovaries are carefully stimulated to create numerous eggs, which are subsequently collected and mixed with sperm in a lab environment.

One or more healthy embryos are chosen for transfer into the woman's uterus after the developing embryos are carefully observed for quality and development. IVF can be customized to treat a variety of infertility factors, including low sperm counts, fallopian tube obstructions, and inexplicable fertility problems.

The global in vitro fertilization market is expected to grow at a steady pace during the forecast period due to several factors such as rise in the median age of first-time mothers and growth in male infertility.

Surge in cases of obesity, alcohol consumption, and public awareness regarding infertility and treatment alternatives is also boosting the demand for IVF.

Attribute Detail
Drivers
  • Rise in Adoption of Assisted Reproductive Technology
  • Technological Advancements in ART

Rise in Adoption of Assisted Reproductive Technology Driving In Vitro Fertilization Market Development

IVF is a process that involves extracting a woman's eggs, fertilizing them in a lab, and then transferring the resulting embryo into the uterus through the cephalic vein which is carried out in fertility clinics in the form of Assisted Reproductive Technology (ART).

Fertility clinics offer specific medical care to individuals and couples who are having difficulty conceiving. These clinics help people reach their intended family planning objectives by providing a variety of treatments such as IVF, egg freezing, artificial conception, and fertility preservation. Hence, increase in adoption of ART is fueling the in vitro fertilization market demand.

According to the Centers for Disease Control and Prevention (CDC)’s 2021 Fertility Clinic Success Rates Report, approximately 238,126 patients had 413,776 ART cycles performed at 453 reporting clinics in the U.S. in 2021, resulting in 91,906 live births (deliveries of one or more living infants) and 97,128 live-born infants.

Of the 413,776 ART cycles performed in 2021, 167,689 were egg or embryo banking cycles in which all resulting eggs or embryos were frozen for future use.

Technological Advancements in ART Augmenting Market Progress

Sperm separation systems are employed in the majority of ARTs such as artificial insemination and IVF since these systems provide refined samples for further processing.

Vendors in the in vitro fertilization market landscape are developing innovative equipment that can be employed in ART operations carried out by fertility clinics and obstetrician-gynecologist (OB/GYN) practices.

In March 2022, Malta took a significant step in the field of reproductive health by collaborating with Pera Labs, a groundbreaking fertility tech company.

The company announced the start of research and development of an AI-powered sperm and egg selection technology for fertility treatments to assist clinics in reducing their standard 70% treatment failure rate.

Growth in utilization of advanced technologies, such as sperm syringes, in selecting quality sperm is expected to create significant in vitro fertilization market opportunities for vendors since these syringes provide clinics with a better way to employ less invasive ARTs and reduce the associated clinical burden and enhance long-term health outcomes for ART-conceived infants.

In Vitro Fertilization Market Regional Insights

Attribute Detail
Leading Region Asia Pacific

According to the latest in vitro fertilization market analysis, Asia Pacific held largest share in 2023. Large population base, declining fertility rates, and increase in number of government-funded initiatives intended for women are propelling the market dynamics of the region.

Surge in awareness regarding infertility is also fueling the in vitro fertilization market share in Asia Pacific. Growth in incidence of infertility can be ascribed to increase in levels of smoking, alcohol consumption, use of some illicit drugs, and underlying problems, including obesity.

Surge in rates of late marriages and pregnancy age is bolstering the in vitro fertilization industry growth in Asia Pacific. According to the study,’ Desire to Delay the First Childbirth Among Young, Married Women in India: A Cross-Sectional Study Based on National Survey Data’, published in 2020, among never pregnant, married women aged 15-24, 21.49% reported a preferred waiting time for their first childbirth of 2 years or more.

Expansion in medical tourism sector is also expected to influence the in vitro fertilization market trends. India is one of the famous destinations for global medical tourism. India provides affordable medical outsourcing facilities to foreign patients seeking a cure for their infertility.

Thus, major international vendors are investing in Indian companies. In 2021, Nova IVF (backed by TPG), acquired a 51% stake in Southend Fertility, a Delhi-based IVF chain.

Analysis of Key Players

Key players operating in the in vitro fertilization industry are developing innovative digital platforms to enhance clinical and scientific decisions with insights gained via artificial intelligence and machine learning to provide targeted treatment regimens.

Vitrolife AB, Cook Medical, Thermo Fisher Scientific, Inc., Merck KGAA, Ovascience, Inc., CooperSurgical, Genea Ltd., Rocket Medical PLC, and Fertility Focus Ltd. are some of the key players operating in this market.

These companies have been profiled in the in vitro fertilization market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.

Key Developments

  • In 2021, CooperSurgical announced a multi-year strategic collaboration with Virtus Health to drive innovation, digitalization, and advancement in fertility treatment. The collaboration will advance Precision Fertility - Virtus’ strategy to develop an innovative digital platform that harnesses the power of Virtus’ significant and unique data set and enhances clinical and scientific decisions with insights gained via artificial intelligence and machine learning.
  • In 2021, CooperCompanies signed a definitive purchase agreement to acquire Generate Life Sciences, a privately held leading provider of donor eggs and sperm for fertility treatments, fertility cryopreservation services, and newborn stem cell storage (cord blood & cord tissue)

In Vitro Fertilization Market Snapshot

Attribute Detail
Market Size in 2023 US$ 781.1 Mn
Market Forecast (Value) in 2034 US$ 1.5 Bn
Growth Rate (CAGR) 6.2%
Forecast Period 2024-2034
Historical Data Available for 2020-2022
Quantitative Units US$ Bn/Mn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2023)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • By Product
    • Equipment
    • Reagents & Media
    • Accessories
  • By Cycle
    • Fresh Non-donor Cycle
    • Frozen Non-donor IVF Cycle
    • Frozen Donor IVF Cycle
    • Fresh Donor IVF Cycle
  • By Type
    • Conventional IVF
    • IVF with ICSI
    • IVF with Donor Eggs
  • By End-user
    • Fertility Clinics
    • Hospitals & Surgical Centers
    • Cryobanks & Research Institutes
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
Companies Profiled
  • Vitrolife AB
  • Cook Medical
  • Thermo Fisher Scientific, Inc.
  • Merck KGAA
  • Ovascience, Inc.
  • CooperSurgical
  • EMD Serono, Inc.
  • Genea Ltd.
  • Rocket Medical PLC
  • Fertility Focus Ltd.
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global in vitro fertilization market in 2023?

It was valued at US$ 781.1 Mn in 2023

How is the in vitro fertilization business expected to grow by 2034?

It is projected to grow at a CAGR of 6.2% from 2024 to 2034

What are the key factors driving the demand for in vitro fertilization?

Rise in adoption of assisted reproductive technology and technological advancements in ART

Which was the major region in the in vitro fertilization landscape in 2023?

Asia Pacific was the leading region in 2023

Who are the key in vitro fertilization vendors?

Vitrolife AB, Cook Medical, Thermo Fisher Scientific, Inc., Merck KGAA, Ovascience, Inc., CooperSurgical, Genea Ltd., Rocket Medical PLC, and Fertility Focus Ltd.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global In Vitro Fertilization Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global In Vitro Fertilization Market Analysis and Forecast, 2020-2034

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product/Brand Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic Impact on Industry

6. Global In Vitro Fertilization Market Analysis and Forecast, by Product

    6.1. Introduction and Definitions

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Product, 2020-2034

        6.3.1. Equipment

        6.3.2. Reagents & Media

        6.3.3. Accessories

    6.4. Market Attractiveness, by Product

7. Global In Vitro Fertilization Market Analysis and Forecast, by Cycle

    7.1. Introduction and Definitions

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Cycle, 2020-2034

        7.3.1. Fresh Non-donor Cycle

        7.3.2. Frozen Non-donor IVF Cycle

        7.3.3. Frozen donor IVF Cycle

        7.3.4. Fresh donor IVF Cycle

    7.4. Market Attractiveness, by Cycle

8. Global In Vitro Fertilization Market Analysis and Forecast, by Type

    8.1. Introduction and Definitions

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by Type, 2020-2034

        8.3.1. Conventional IVF

        8.3.2. IVF with ICSI

        8.3.3. IVF with Donor Eggs

    8.4. Market Attractiveness, by Type

9. Global In Vitro Fertilization Market Analysis and Forecast, by End-user

    9.1. Introduction and Definitions

    9.2. Key Findings/Developments

    9.3. Market Value Forecast, by End-user, 2020-2034

        9.3.1. Fertility Clinics

        9.3.2. Hospitals & Surgical Centers

        9.3.3. Cryobanks & Research Institutes

    9.4. Market Attractiveness, by End-user

10. Global In Vitro Fertilization Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region, 2020-2034

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Market Attractiveness, by Region

11. North America In Vitro Fertilization Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2020-2034

        11.2.1. Equipment

        11.2.2. Reagents & Media

        11.2.3. Accessories

    11.3. Market Attractiveness, by Product

    11.4. Market Value Forecast, by Cycle, 2020-2034

        11.4.1. Fresh Non-donor Cycle

        11.4.2. Frozen Non-donor IVF Cycle

        11.4.3. Frozen donor IVF Cycle

        11.4.4. Fresh donor IVF Cycle

    11.5. Market Attractiveness, by Cycle

    11.6. Market Value Forecast, by Type, 2020-2034

        11.6.1. Conventional IVF

        11.6.2. IVF with ICSI

        11.6.3. IVF with Donor Eggs

    11.7. Market Attractiveness, by Type

    11.8. Market Value Forecast, by End-user, 2020-2034

        11.8.1. Fertility Clinics

        11.8.2. Hospitals & Surgical Centers

        11.8.3. Cryobanks & Research Institutes

    11.9. Market Attractiveness, by End-user

    11.10. Market Value Forecast, by Country/Sub-region, 2020-2034

        11.10.1. U.S.

        11.10.2. Canada

    11.11. Market Attractiveness Analysis

        11.11.1. By Product

        11.11.2. By Cycle

        11.11.3. By Type

        11.11.4. By End-user

        11.11.5. By Country

12. Europe In Vitro Fertilization Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2020-2034

        12.2.1. Equipment

        12.2.2. Reagents & Media

        12.2.3. Accessories

    12.3. Market Attractiveness, by Product

    12.4. Market Value Forecast, by Cycle, 2020-2034

        12.4.1. Fresh Non-donor Cycle

        12.4.2. Frozen Non-donor IVF Cycle

        12.4.3. Frozen donor IVF Cycle

        12.4.4. Fresh donor IVF Cycle

    12.5. Market Attractiveness, by Cycle

    12.6. Market Value Forecast, by Type, 2020-2034

        12.6.1. Conventional IVF

        12.6.2. IVF with ICSI

        12.6.3. IVF with Donor Eggs

    12.7. Market Attractiveness, by Type

    12.8. Market Value Forecast, by End-user, 2020-2034

        12.8.1. Fertility Clinics

        12.8.2. Hospitals & Surgical Centers

        12.8.3. Cryobanks & Research Institutes

    12.9. Market Attractiveness, by End-user

    12.10. Market Value Forecast, by Country/Sub-region, 2020-2034

        12.10.1. Germany

        12.10.2. U.K.

        12.10.3. France

        12.10.4. Italy

        12.10.5. Spain

        12.10.6. Rest of Europe

    12.11. Market Attractiveness Analysis

        12.11.1. By Product

        12.11.2. By Cycle

        12.11.3. By Type

        12.11.4. By End-user

        12.11.5. By Country/Sub-region

13. Asia Pacific In Vitro Fertilization Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2020-2034

        13.2.1. Equipment

        13.2.2. Reagents & Media

        13.2.3. Accessories

    13.3. Market Attractiveness, by Product

    13.4. Market Value Forecast, by Cycle, 2020-2034

        13.4.1. Fresh Non-donor Cycle

        13.4.2. Frozen Non-donor IVF Cycle

        13.4.3. Frozen donor IVF Cycle

        13.4.4. Fresh donor IVF Cycle

    13.5. Market Attractiveness, by Cycle

    13.6. Market Value Forecast, by Type, 2020-2034

        13.6.1. Conventional IVF

        13.6.2. IVF with ICSI

        13.6.3. IVF with Donor Eggs

    13.7. Market Attractiveness, by Type

    13.8. Market Value Forecast, by End-user, 2020-2034

        13.8.1. Fertility Clinics

        13.8.2. Hospitals & Surgical Centers

        13.8.3. Cryobanks & Research Institutes

    13.9. Market Attractiveness, by End-user

    13.10. Market Value Forecast, by Country/Sub-region, 2020-2034

        13.10.1. China

        13.10.2. Japan

        13.10.3. India

        13.10.4. Australia & New Zealand

        13.10.5. Rest of Asia Pacific

    13.11. Market Attractiveness Analysis

        13.11.1. By Product

        13.11.2. By Cycle

        13.11.3. By Type

        13.11.4. By End-user

        13.11.5. By Country/Sub-region

14. Latin America In Vitro Fertilization Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product, 2020-2034

        14.2.1. Equipment

        14.2.2. Reagents & Media

        14.2.3. Accessories

    14.3. Market Attractiveness, by Product

    14.4. Market Value Forecast, by Cycle, 2020-2034

        14.4.1. Fresh Non-donor Cycle

        14.4.2. Frozen Non-donor IVF Cycle

        14.4.3. Frozen donor IVF Cycle

        14.4.4. Fresh donor IVF Cycle

    14.5. Market Attractiveness, by Cycle

    14.6. Market Value Forecast, by Type, 2020-2034

        14.6.1. Conventional IVF

        14.6.2. IVF with ICSI

        14.6.3. IVF with Donor Eggs

    14.7. Market Attractiveness, by Type

    14.8. Market Value Forecast, by End-user, 2020-2034

        14.8.1. Fertility Clinics

        14.8.2. Hospitals & Surgical Centers

        14.8.3. Cryobanks & Research Institutes

    14.9. Market Attractiveness, by End-user

    14.10. Market Value Forecast, by Country/Sub-region, 2020-2034

        14.10.1. Brazil

        14.10.2. Mexico

        14.10.3. Rest of Latin America

    14.11. Market Attractiveness Analysis

        14.11.1. By Product

        14.11.2. By Cycle

        14.11.3. By Type

        14.11.4. By End-user

        14.11.5. By Country/Sub-region

15. Middle East & Africa In Vitro Fertilization Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Product, 2020-2034

        15.2.1. Equipment

        15.2.2. Reagents & Media

        15.2.3. Accessories

    15.3. Market Attractiveness, by Product

    15.4. Market Value Forecast, by Cycle, 2020-2034

        15.4.1. Fresh Non-donor Cycle

        15.4.2. Frozen Non-donor IVF Cycle

        15.4.3. Frozen donor IVF Cycle

        15.4.4. Fresh donor IVF Cycle

    15.5. Market Attractiveness, by Cycle

    15.6. Market Value Forecast, by Type, 2020-2034

        15.6.1. Conventional IVF

        15.6.2. IVF with ICSI

        15.6.3. IVF with Donor Eggs

    15.7. Market Attractiveness, by Type

    15.8. Market Value Forecast, by End-user, 2020-2034

        15.8.1. Fertility Clinics

        15.8.2. Hospitals & Surgical Centers

        15.8.3. Cryobanks & Research Institutes

    15.9. Market Attractiveness, by End-user

    15.10. Market Value Forecast, by Country/Sub-region, 2020-2034

        15.10.1. GCC Countries

        15.10.2. South Africa

        15.10.3. Rest of Middle East & Africa

    15.11. Market Attractiveness Analysis

        15.11.1. By Product

        15.11.2. By Cycle

        15.11.3. By Type

        15.11.4. By End-user

        15.11.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player - Competition Matrix (By Tier and Size of Companies)

    16.2. Market Share Analysis, by Company (2023)

    16.3. Company Profiles

        16.3.1. Vitrolife AB

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Product Portfolio

            16.3.1.3. Financial Overview

            16.3.1.4. SWOT Analysis

            16.3.1.5. Strategic Overview

        16.3.2. Cook Medical

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Product Portfolio

            16.3.2.3. Financial Overview

            16.3.2.4. SWOT Analysis

            16.3.2.5. Strategic Overview

        16.3.3. Thermo Fisher Scientific, Inc.

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Product Portfolio

            16.3.3.3. Financial Overview

            16.3.3.4. SWOT Analysis

            16.3.3.5. Strategic Overview

        16.3.4. Merck KGAA

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Product Portfolio

            16.3.4.3. Financial Overview

            16.3.4.4. SWOT Analysis

            16.3.4.5. Strategic Overview

        16.3.5. Ovascience, Inc.

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Product Portfolio

            16.3.5.3. Financial Overview

            16.3.5.4. SWOT Analysis

            16.3.5.5. Strategic Overview

        16.3.6. CooperSurgical

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Product Portfolio

            16.3.6.3. Financial Overview

            16.3.6.4. SWOT Analysis

            16.3.6.5. Strategic Overview

        16.3.7. Genea Ltd.

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Product Portfolio

            16.3.7.3. Financial Overview

            16.3.7.4. SWOT Analysis

            16.3.7.5. Strategic Overview

        16.3.8. Rocket Medical PLC

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Product Portfolio

            16.3.8.3. Financial Overview

            16.3.8.4. SWOT Analysis

            16.3.8.5. Strategic Overview

        16.3.9. Fertility Focus Ltd.

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Product Portfolio

            16.3.9.3. Financial Overview

            16.3.9.4. SWOT Analysis

            16.3.9.5. Strategic Overview

List of Tables

Table 01: Global In Vitro Fertilization Market Size (US$ Mn) Forecast, by Product, 2020-2034

Table 02: Global In Vitro Fertilization Market Size (US$ Mn) Forecast, by Cycle, 2020-2034

Table 03: Global In Vitro Fertilization Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 04: Global In Vitro Fertilization Market Size (US$ Mn) Forecast, by Type, 2020-2034

Table 05: Global In Vitro Fertilization Market Size (US$ Mn) Forecast, by Region, 2020-2034

Table 06: North America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Country, 2020-2034

Table 07: North America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Product, 2020-2034

Table 08: North America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Cycle, 2020-2034

Table 09: North America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Type, 2020-2034

Table 10: North America In Vitro Fertilization Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 11: Europe In Vitro Fertilization Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 12: Europe In Vitro Fertilization Market Size (US$ Mn) Forecast, by Product, 2020-2034

Table 13: Europe In Vitro Fertilization Market Size (US$ Mn) Forecast, by Cycle, 2020-2034

Table 14: Europe In Vitro Fertilization Market Size (US$ Mn) Forecast, by Type, 2020-2034

Table 15: Europe In Vitro Fertilization Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 16: Asia Pacific In Vitro Fertilization Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 17: Asia Pacific In Vitro Fertilization Market Size (US$ Mn) Forecast, by Product, 2020-2034

Table 18: Asia Pacific In Vitro Fertilization Market Size (US$ Mn) Forecast, by Cycle, 2020-2034

Table 19: Asia Pacific In Vitro Fertilization Market Size (US$ Mn) Forecast, by Type, 2020-2034

Table 20: Asia Pacific In Vitro Fertilization Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 21: Latin America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 22: Latin America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Product, 2020-2034

Table 23: Latin America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Cycle, 2020-2034

Table 24: Latin America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Type, 2020-2034

Table 25: Latin America In Vitro Fertilization Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 26: Middle East & Africa In Vitro Fertilization Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 27: Middle East & Africa In Vitro Fertilization Market Size (US$ Mn) Forecast, by Product, 2020-2034

Table 28: Middle East & Africa In Vitro Fertilization Market Size (US$ Mn) Forecast, by Cycle, 2020-2034

Table 29: Middle East & Africa In Vitro Fertilization Market Size (US$ Mn) Forecast, by Type, 2020-2034

Table 30: Middle East & Africa In Vitro Fertilization Market Size (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

Figure 01: Global In Vitro Fertilization Market Size (US$ Mn), by Region, 2023 and 2034

Figure 02: Global In Vitro Fertilization Market Revenue (US$ Mn), by Product, 2023

Figure 03: Global In Vitro Fertilization Market Value Share, by Product, 2023

Figure 04: Global In Vitro Fertilization Market Revenue (US$ Mn), by Cycle, 2023

Figure 05: Global In Vitro Fertilization Market Value Share, by Cycle, 2023

Figure 06: Global In Vitro Fertilization Market Revenue (US$ Mn), by Type, 2023

Figure 07: Global In Vitro Fertilization Market Value Share, by Type, 2023

Figure 08: Global In Vitro Fertilization Market Revenue (US$ Mn), by End-user, 2023

Figure 09: Global In Vitro Fertilization Market Value Share, by End-user, 2023

Figure 10: Global In Vitro Fertilization Market Value Share, by Region, 2023

Figure 11: Global In Vitro Fertilization Market Value (US$ Mn) Forecast, 2020-2034

Figure 12: Global In Vitro Fertilization Market Value Share Analysis, by Product, 2023 and 2034

Figure 13: Global In Vitro Fertilization Market Attractiveness Analysis, by Product, 2024-2034

Figure 14: Global In Vitro Fertilization Market Value Share Analysis, by Cycle, 2023 and 2034

Figure 15: Global In Vitro Fertilization Market Attractiveness Analysis, by Cycle, 2024-2034

Figure 16: Global In Vitro Fertilization Market Value Share Analysis, by Type, 2023 and 2034

Figure 17: Global In Vitro Fertilization Market Attractiveness Analysis, by Type, 2024-2034

Figure 18: Global In Vitro Fertilization Market Revenue (US$ Mn), by End-user, 2023

Figure 19: Global In Vitro Fertilization Market Value Share, by End-user, 2023

Figure 20: Global In Vitro Fertilization Market Value Share Analysis, by Region, 2023 and 2034

Figure 21: Global In Vitro Fertilization Market Attractiveness Analysis, by Region, 2024-2034

Figure 22: North America In Vitro Fertilization Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 23: North America In Vitro Fertilization Market Attractiveness Analysis, by Country, 2024-2034

Figure 24: North America In Vitro Fertilization Market Value Share Analysis, by Country, 2023 and 2034

Figure 25: North America In Vitro Fertilization Market Value Share Analysis, by Product, 2023 and 2034

Figure 26: North America In Vitro Fertilization Market Value Share Analysis, by Cycle, 2023 and 2034

Figure 27: North America In Vitro Fertilization Market Value Share Analysis, by Type, 2023 and 2034

Figure 28: North America In Vitro Fertilization Market Value Share Analysis, by End-user, 2023 and 2034

Figure 29: North America In Vitro Fertilization Market Attractiveness Analysis, by Product, 2024-2034

Figure 30: North America In Vitro Fertilization Market Attractiveness Analysis, by Cycle, 2024-2034

Figure 31: North America In Vitro Fertilization Market Attractiveness Analysis, by Type, 2024-2034

Figure 32: North America In Vitro Fertilization Market Attractiveness Analysis, by End-user, 2024-2034

Figure 33: Europe In Vitro Fertilization Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 34: Europe In Vitro Fertilization Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 35: Europe In Vitro Fertilization Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 36: Europe In Vitro Fertilization Market Value Share Analysis, by Product, 2023 and 2034

Figure 37: Europe In Vitro Fertilization Market Value Share Analysis, by Cycle, 2023 and 2034

Figure 38: Europe In Vitro Fertilization Market Value Share Analysis, by Type, 2023 and 2034

Figure 39: Europe In Vitro Fertilization Market Value Share Analysis, by End-user, 2023 and 2034

Figure 40: Europe In Vitro Fertilization Market Attractiveness Analysis, by Product, 2024-2034

Figure 41: Europe In Vitro Fertilization Market Attractiveness Analysis, by Cycle, 2024-2034

Figure 42: Europe In Vitro Fertilization Market Attractiveness Analysis, by Type, 2024-2034

Figure 43: Europe In Vitro Fertilization Market Attractiveness Analysis, by End-user, 2024-2034

Figure 44: Asia Pacific In Vitro Fertilization Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 45: Asia Pacific In Vitro Fertilization Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 46: Asia Pacific In Vitro Fertilization Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 47: Asia Pacific In Vitro Fertilization Market Value Share Analysis, by Product, 2023 and 2034

Figure 48: Asia Pacific In Vitro Fertilization Market Value Share Analysis, by Cycle, 2023 and 2034

Figure 49: Asia Pacific In Vitro Fertilization Market Value Share Analysis, by Type, 2023 and 2034

Figure 50: Asia Pacific In Vitro Fertilization Market Value Share Analysis, by End-user, 2023 and 2034

Figure 51: Asia Pacific In Vitro Fertilization Market Attractiveness Analysis, by Product, 2024-2034

Figure 52: Asia Pacific In Vitro Fertilization Market Attractiveness Analysis, by Cycle, 2024-2034

Figure 53: Asia Pacific In Vitro Fertilization Market Attractiveness Analysis, by Type, 2024-2034

Figure 54: Asia Pacific In Vitro Fertilization Market Attractiveness Analysis, by End-user, 2023-2034

Figure 55: Latin America In Vitro Fertilization Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 56: Latin America In Vitro Fertilization Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 57: Latin America In Vitro Fertilization Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 58: Latin America In Vitro Fertilization Market Value Share Analysis, by Product, 2023 and 2034

Figure 59: Latin America In Vitro Fertilization Market Value Share Analysis, by Cycle, 2023 and 2034

Figure 60: Latin America In Vitro Fertilization Market Value Share Analysis, by Type, 2023 and 2034

Figure 61: Latin America In Vitro Fertilization Market Value Share Analysis, by End-user, 2023 and 2034

Figure 62: Latin America In Vitro Fertilization Market Attractiveness Analysis, by Product, 2024-2034

Figure 63: Latin America In Vitro Fertilization Market Attractiveness Analysis, by Cycle, 2024-2034

Figure 64: Latin America In Vitro Fertilization Market Attractiveness Analysis, by Type, 2024-2034

Figure 65: Latin America In Vitro Fertilization Market Attractiveness Analysis, by End-user, 2024-2034

Figure 66: Middle East & Africa In Vitro Fertilization Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 67: Middle East & Africa In Vitro Fertilization Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 68: Middle East & Africa In Vitro Fertilization Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 69: Middle East & Africa In Vitro Fertilization Market Value Share Analysis, by Product, 2023 and 2034

Figure 70: Middle East & Africa In Vitro Fertilization Market Value Share Analysis, by Cycle, 2023 and 2034

Figure 71: Middle East & Africa In Vitro Fertilization Market Value Share Analysis, by Type, 2023 and 2034

Figure 72: Middle East & Africa In Vitro Fertilization Market Value Share Analysis, by End-user, 2023 and 2034

Figure 73: Middle East & Africa In Vitro Fertilization Market Attractiveness Analysis, by Product, 2024-2034

Figure 74: Middle East & Africa In Vitro Fertilization Market Attractiveness Analysis, by Cycle, 2024-2034

Figure 75: Middle East & Africa In Vitro Fertilization Market Attractiveness Analysis, by Type, 2024-2034

Figure 76: Middle East & Africa In Vitro Fertilization Market Attractiveness Analysis, by End-user, 2024-2034

Copyright © Transparency Market Research, Inc. All Rights reserved